German Health Minister Jens Spahn affirmed that CureVac Company will only develop vaccines for the whole world, not produce them for any country. Ministers in the German Government reacted angrily after it was reported that US President Donald Trump was trying to persuade German scientists to cooperate in obtaining the US license to produce exclusive vaccine against corona virus new (SARS-CoV-2) caused the Covid-19 disease.
“Germany is not for sale,” German Economy Minister Peter Altmaier told ARD broadcaster when asked to comment on information posted on the front page of the Welt am Sonntag newspaper with the headline: “The match between Trump and Berlin”.
The newspaper said that US President Donald Trump offered to spend US $ 1 billion on bio-drug company CureVac, based in Thuringia state, to ensure that the company only produces vaccines against Covid-19 for the United States.
The German government is believed to be providing financial incentives to keep the anti-Covid-19 vaccine in the country.
The above information has ignited anger in Berlin. Erwin Rueddel, a conservative legislator on the medical committee of the German Parliament, said: “In the current context, the cooperation of the international community is important, not the interests of any country.” .
Christian Lindner, the leader of the Free FDP, accused Trump of using the vaccine monopoly as a boost to the upcoming US presidential campaign: “It is clear that Mr. Trump will use any means. maybe in my campaign. “
German Health Minister Jens Spahn has also denied the Trump administration’s ability to monopolize CureVac’s vaccine product. Mr. Spahn confirmed that CureVac will only develop vaccines for the whole world, not produce them for any country.
According to statistics from Johns Hopkins University, the number of cases worldwide except China has exceeded 88,000 cases. Meanwhile, this figure in mainland China alone as of March 16 was 80,860 cases. The number of deaths outside of China also soared to 3,305 people, while mainland China as of the same day recorded 3,213 patients who died of Covid-19. Since the outbreak in Wuhan City in December 2019 to March 16, the total number of infections worldwide has exceeded 169,000, including more than 6,500 deaths from corona virus infection.
At a press conference on March 15 (local time), German Interior Minister Horst Seehofer, when asked about information related to the incident, said: “I can only say that I have several times today. listen to this from Government officials and we will discuss it tomorrow. ”
A US official yesterday told AFP that the information had been “overblown”. “The US government has worked with many companies [more than 25 companies] claiming that they can help produce vacccine,” the official said. Most of these companies have received initial funding from US investors. ”
The unnamed official also denied that the US was seeking to keep any potential vaccine on its own, insisting the US government would continue to work with any company that claimed it could help produce the vaccine. . He pointed out, any solution when feasible will be shared with the world.
CureVac, founded in 2000, is headquartered in the German state of Thuringia and has offices in Frankfurt and Boston. The Self-Advertising Company specializes in developing anti-cancer therapies, antibody-based therapies, treatment of rare diseases and production of prophylactic vaccines.
The company’s laboratory is working in tandem with the Paul-Ehrlich Institute, affiliated with the German Ministry of Health.
Last week, the company secretly announced that CureVac CEO Daniel Menichella was replaced by Ingmar Hoerr, just weeks after Menichella met US President Donald Trump, Vice President Mike Pence and representatives of the companies. Pharmaceutical company in Washington.
Earlier, CureVac quoted Menichella posted on the company’s website shortly after the US visit: “We are confident that we will be able to develop a vaccine as ‘a bright candidate’ [of choice]. choose a vaccine to treat Covid-19-ND in a few months ”.
Yesterday (March 15), CureVac’s investors said they would not sell the vaccine to a single country.
In a statement, Dietmar Hopp, the head of dievini Hopp BioTech’s chief investor, said: “If we succeed in developing an effective vaccine, it will help and protect everyone around the world. world”.
German Economy Minister Peter Altmaier welcomed and called it a great decision.
Mr. Altmaier also pointed out that the Government has the right to scrutinize cases for foreigners to take over: “Where there are important infrastructures related to national and European interests. , we will take action if we are required to do so.”